During tumor progression, TGF-β1 can be produced by tumor cells and/or the surrounding stromal cells; the growth inhibition effect of TGF-β1 is reduced or eliminated, and thus, tumor cell growth becomes dominant. Here, TGFB1 is linked to neoplasm.